DOI: http://dx.doi.org/10.18203/2349-3291.ijcp20212057

Congenital toxoplasmosis the overlooked disease: a case report

Mahmoud M. Osman, Eiman S. Albadani, Suzan Abdel-Hamid, Sulafa A. Hamdoun, Naif A. Alruwaished

Abstract


The causative agent of congenital toxoplasmosis (CT) is Toxoplasma gondii, an obligate intracellular parasitic protozoan presenting as a zoonotic infection distributed worldwide. Congenital toxoplasmosis may lead to abortion, intrauterine growth restriction, hepatosplenomegaly, jaundice and several neurological and ocular manifestations. The classic pathognomonic manifestations are the triad of intracranial calcifications, hydrocephalus and chorioretinitis. However, the majority of infected infants are asymptomatic at birth. Herein, we reported a case of severe CT in a late preterm newborn. Interestingly, the majority of the manifestations reported for CT were observed in this case. The high anti-toxoplasma antibodies (IgM and IgG) in the infant and his mother confirmed the diagnosis.

 


Keywords


Toxoplasma gondii, Congenital toxoplasmosis, Hydrocephalus, Intracranial calcification, Chorioretinitis

Full Text:

PDF

References


Konstantinovic N, Guegan H, Stäjner T, Belaz S, Robert-Gangneux F. Treatment of toxoplasmosis: Current options and future perspectives. Food Waterborne Parasitol. 2019;12:1-15.

Maldonado YA, Read JS, Committee on Infectious Diseases. Diagnosis, treatment and prevention of congenital toxoplasmosis in the United States. Pediatrics. 2017;139(2):20163860.

Wild BM, Obringer E, Farrell E. Evaluation and treatment of fetal exposure to toxoplasmosis. Neoreviews. 2015;16(4):236-9.

Christelle P, Montoya JG. Laboratory diagnosis of congenital toxoplasmosis. J Clin Microbiol. 2016;54(10):2448-54.

Hampton MM. Congenital toxoplasmosis: a review. Neonatal Netw. 2015;34(5):274-8.

Saso A, Bamford A, Grewal K, Noori M, Hatcher J, D’Arco F, et al. Fifteen-minute consultation: Management of the infant born to a mother with toxoplasmosis in pregnancy. Arch Dis Child Educ Pract Ed. 2020;105(5):262-9.

Peyron F, L’ollivier C, Mandelbrot L, Wallon M, Piarroux R, Kieffer F, et al. Maternal and congenital toxoplasmosis: diagnosis and treatment recommendations of a French multidisciplinary working group. Pathogens. 2019;8(24):1-15.

McLeod R, Lykins J, Noble GA, Rabiah P, Swisher CN, Heydemann PT, et al. Management of congenital toxoplasmosis. Curr Pediatr Rep. 2014;2:166-94.

Khan K, Khan W. Congenital toxoplasmosis: an overview of the neurological and ocular manifestations. Parasitol Int. 2018;67(6):715-21.

Beltrán-Flores S, Flores-Arriaga J, Lema-Correa M. Hospital Infantil de México (English Edition). Bol Med Hosp Infant Mex. 2014;71(6):373-6.

Singh S. Congenital toxoplasmosis: clinical features, outcomes, treatment and prevention. Trop Parasitol. 2016;6(2):113-22.

Serranti D, Buonsenso D, Valentini P. Congenital toxoplasmosis treatment. Eur Rev Med Pharmacol Sci. 2011;(15):193-8.

Al-Agroudi MA, Ahmad GMS, Kondo KM, Morsy TA. An overview of congenital toxoplasmosis: Clinical features, diagnosis, treatment and prevention. J Egypt Soc Parasitol. 2017;47(3):523-40.

Kundu GK, Nandi ER, Saha A, Habib A, Rahman MM. Congenital toxoplasmosis associated with severe intracerebral calcification and West syndrome. Bangladesh Med J. 2014;43(3):165-7.